{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T04:51:16Z","timestamp":1768107076331,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mean arterial pressure to mean pulmonary arterial pressure ratio (mAP\/mPAP) has been identified as a strong predictor of perioperative complications in cardiac surgery. We therefore investigated the pharmacokinetic\/pharmacodynamic (PK\/PD) relationship of inhaled milrinone in these patients using this ratio (R) as a PD marker. Following approval by the ethics and research committee and informed consent, we performed the following experiment. Before initiation of cardiopulmonary bypass in 28 pulmonary hypertensive patients scheduled for cardiac surgery, milrinone (5\u00a0mg) was nebulized, plasma concentrations measured (up to 10\u00a0h) and compartmental PK analysis carried out. Baseline (R<jats:sub>0<\/jats:sub>) and peak (R<jats:sub>max<\/jats:sub>) ratios as well as magnitude of peak response (\u2206<jats:sub>Rmax-R0<\/jats:sub>) were measured. During inhalation, individual area under effect-time (AUEC) and plasma concentration\u2013time (AUC) curves were correlated. Potential relationships between PD markers and difficult separation from bypass (DSB) were explored. In this study, we observed that milrinone peak concentrations (41\u2013189\u00a0ng\u00a0ml<jats:sup>\u22121<\/jats:sup>) and \u0394<jats:sub>Rmax-R0<\/jats:sub> (\u2212\u00a00.12\u20131.5) were obtained at the end of inhalation (10\u201330\u00a0min). Mean PK parameters agreed with intravenous milrinone published data after correction for the estimated inhaled dose. Paired comparisons yielded a statistically significant increase between R<jats:sub>0<\/jats:sub> and R<jats:sub>max<\/jats:sub> (mean difference, 0.58: 95% CI 0.43\u20130.73; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Individual AUEC correlated with AUC (r\u2009=\u20090.3890, r<jats:sup>2<\/jats:sup>\u2009=\u20090.1513; <jats:italic>P<\/jats:italic>\u2009=\u20090.045); significance increased after exclusion of non-responders (r\u2009=\u20094787, r<jats:sup>2<\/jats:sup>\u2009=\u20090.2292; <jats:italic>P<\/jats:italic>\u2009=\u20090.024). Individual AUEC correlated with \u2206R<jats:sub>max-R0<\/jats:sub> (r\u2009=\u20095973, r<jats:sup>2<\/jats:sup>\u2009=\u20090.3568; <jats:italic>P<\/jats:italic>\u2009=\u20090.001). Both \u2206R<jats:sub>max-R0<\/jats:sub> (<jats:italic>P<\/jats:italic>\u2009=\u20090.009) and CPB duration (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) were identified as predictors of DSB. In conclusion, both magnitude of peak response of the mAP\/mPAP ratio and CPB duration were associated with DSB.<\/jats:p>","DOI":"10.1038\/s41598-023-29945-7","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T14:03:14Z","timestamp":1677765794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inhaled milrinone in cardiac surgical patients: pharmacokinetic and pharmacodynamic exploration"],"prefix":"10.1038","volume":"13","author":[{"given":"Anne Quynh-Nhu","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Y.","family":"Denault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Th\u00e9oret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Varin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"29945_CR1","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/j.jvca.2012.03.031","volume":"26","author":"AY Denault","year":"2012","unstructured":"Denault, A. Y., Tardif, J. C., Mazer, C. D. & Lambert, J. Difficult and complex separation from cardiopulmonary bypass in high-risk cardiac surgical patients: A multicenter study. J. Cardiothorac. Vasc. Anesth. 26, 608\u2013616 (2012).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR2","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1213\/00000539-199910000-00002","volume":"89","author":"DL Reich","year":"1999","unstructured":"Reich, D. L. et al. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth. Analg. 89, 814\u2013822 (1999).","journal-title":"Anesth. Analg."},{"key":"29945_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1378\/chest.102.1.36","volume":"102","author":"KJ Tuman","year":"1992","unstructured":"Tuman, K. J., McCarthy, R. J., March, R. J., Najafi, H. & Ivankovich, A. D. Morbidity and duration of ICU stay after cardiac surgery: A model for preoperative risk assessment. Chest 102, 36\u201344 (1992).","journal-title":"Chest"},{"key":"29945_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0735-1097(02)02002-8","volume":"40","author":"JF Malouf","year":"2002","unstructured":"Malouf, J. F. et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: Clinical profile and prognostic implications. J. Am. Coll. Cardiol. 40, 789\u2013795 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"29945_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1053\/j.jvca.2005.11.018","volume":"20","author":"A Robitaille","year":"2006","unstructured":"Robitaille, A. et al. Importance of relative pulmonary hypertension in cardiac surgery: The mean systemic-to-pulmonary artery pressure ratio. J. Cardiothorac. Vasc. Anesth. 20, 331\u2013339 (2006).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.jvca.2013.03.016","volume":"27","author":"JC Bianco","year":"2013","unstructured":"Bianco, J. C. et al. Is patient-prosthesis mismatch a perioperative predictor of long-term mortality after aortic valve replacement?. J. Cardiothorac. Vasc. Anesth. 27, 647\u2013653 (2013).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR7","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.4254\/wjh.v8.i32.1384","volume":"8","author":"A Rebel","year":"2016","unstructured":"Rebel, A. et al. Systemic-to-pulmonary artery pressure ratio as a predictor of patient outcome following liver transplantation. World J. Hepatol. 8, 1384\u20131391 (2016).","journal-title":"World J. Hepatol."},{"key":"29945_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.jvca.2017.09.017","volume":"32","author":"JC Bianco","year":"2018","unstructured":"Bianco, J. C. et al. Heart transplantation in patients >60 years: Importance of relative pulmonary hypertension and right ventricular failure on midterm survival. J. Cardiothorac. Vasc. Anesth. 32, 32\u201340 (2018).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.jvca.2018.08.190","volume":"33","author":"SA Schubert","year":"2019","unstructured":"Schubert, S. A. et al. Pulmonary-systemic pressure ratio correlates with morbidity in cardiac valve surgery. J. Cardiothorac. Vasc. Anesth. 33, 677\u2013682 (2019).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR10","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1053\/j.jvca.2020.12.010","volume":"35","author":"JC Bianco","year":"2021","unstructured":"Bianco, J. C. et al. Acute kidney injury after heart transplant: The importance of pulmonary hypertension. J. Cardiothorac. Vasc. Anesth. 35, 2052\u20132062 (2021).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR11","first-page":"192","volume":"4","author":"A Denault","year":"2014","unstructured":"Denault, A., Haddad, F., Lamarche, Y., Nguyen, A. & Varin, F. Pilot randomized controlled trial of inhaled milrinone in high-risk cardiac surgical patients. Surg. Curr. Res. 4, 192 (2014).","journal-title":"Surg. Curr. Res."},{"key":"29945_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/j.jvca.2014.06.012","volume":"29","author":"M Laflamme","year":"2015","unstructured":"Laflamme, M. et al. Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension. J. Cardiothorac. Vasc. Anesth. 29, 38\u201345 (2015).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1053\/j.jvca.2012.10.017","volume":"28","author":"P St-Pierre","year":"2014","unstructured":"St-Pierre, P., Deschamps, A., Cartier, R., Basmadjian, A. J. & Denault, A. Y. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma. J. Cardiothorac. Vasc. Anesth. 28, 723\u2013729 (2014).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/echo.12468","volume":"31","author":"F Haddad","year":"2014","unstructured":"Haddad, F. et al. Septal curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension. Echocardiography 31, 699\u2013707 (2014).","journal-title":"Echocardiography"},{"key":"29945_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1053-0770(97)90250-0","volume":"11","author":"LA Doolan","year":"1997","unstructured":"Doolan, L. A., Jones, E. F., Kalman, J., Buxton, B. F. & Tonkin, A. M. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 11, 37\u201341 (1997).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S1053-0770(00)90048-X","volume":"14","author":"A Solina","year":"2000","unstructured":"Solina, A. et al. A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients. J. Cardiothorac. Vasc. Anesth. 14, 12\u201317 (2000).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1053\/jcan.2001.23274","volume":"15","author":"RO Feneck","year":"2001","unstructured":"Feneck, R. O., Sherry, K. M., Withington, P. S. & Oduro-Dominah, A. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 15, 306\u2013315 (2001).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0952-8180(01)00270-7","volume":"13","author":"AR Solina","year":"2001","unstructured":"Solina, A. R. et al. Dose response to nitric oxide in adult cardiac surgery patients. J. Clin. Anesth. 13, 281\u2013286 (2001).","journal-title":"J. Clin. Anesth."},{"key":"29945_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1172\/JCI111742","volume":"75","author":"BE Jaski","year":"1985","unstructured":"Jaski, B. E., Fifer, M. A., Wright, R. F., Braunwald, E. & Colucci, W. S. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: Dose-response relationships and comparison to nitroprusside. J. Clin. Invest. 75, 643\u2013649 (1985).","journal-title":"J. Clin. Invest."},{"key":"29945_CR20","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"MS Cuffe","year":"2002","unstructured":"Cuffe, M. S. et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA 287, 1541\u20131547 (2002).","journal-title":"JAMA"},{"key":"29945_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF03022314","volume":"54","author":"P Couture","year":"2007","unstructured":"Couture, P., Denault, A. Y., Pellerin, M. & Tardif, J. C. Milrinone enhances systolic, but not diastolic function during coronary artery bypass grafting surgery. Can. J. Anesth. 54, 509\u2013522 (2007).","journal-title":"Can. J. Anesth."},{"key":"29945_CR22","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1097\/00000539-200112000-00018","volume":"93","author":"A Haraldsson","year":"2001","unstructured":"Haraldsson, A., Kieler-Jensen, N. & Ricksten, S. E. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth. Analg. 93, 1439\u20131445 (2001).","journal-title":"Anesth. Analg."},{"key":"29945_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/BF03021608","volume":"52","author":"A Sablotzki","year":"2005","unstructured":"Sablotzki, A., Starzmann, W., Scheubel, R., Grond, S. & Czeslick, E. G. Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates. Can. J. Anesth. 52, 1076\u20131082 (2005).","journal-title":"Can. J. Anesth."},{"key":"29945_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s12325-009-0019-4","volume":"26","author":"H Wang","year":"2009","unstructured":"Wang, H., Gong, M., Zhou, B. & Dai, A. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Adv. Ther. 26, 462\u2013468 (2009).","journal-title":"Adv. Ther."},{"key":"29945_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jtcvs.2004.09.011","volume":"130","author":"Y Lamarche","year":"2005","unstructured":"Lamarche, Y. et al. Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 130, 83\u201392 (2005).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"29945_CR26","first-page":"38","volume":"6","author":"N Hegazy","year":"2010","unstructured":"Hegazy, N. & Elhenawy, A. Comparison of hemodynamic effects of inhaled milrinone and inhaled prostacyclin after adult cardiac surgery. J. Appl. Sci. Res. 6, 38\u201344 (2010).","journal-title":"J. Appl. Sci. Res."},{"key":"29945_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000332411","volume":"21","author":"M Gong","year":"2012","unstructured":"Gong, M., Lin, X. Z., Lu, G. T. & Zheng, L. J. Preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass. Med. Princ. Pract. 21, 30\u201335 (2012).","journal-title":"Med. Princ. Pract."},{"key":"29945_CR28","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ejcts.2007.02.019","volume":"31","author":"Y Lamarche","year":"2007","unstructured":"Lamarche, Y. et al. Preliminary experience with inhaled milrinone in cardiac surgery. Eur. J. Cardiothorac. Surg. 31, 1081\u20131087 (2007).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"29945_CR29","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s12630-016-0709-8","volume":"63","author":"AY Denault","year":"2016","unstructured":"Denault, A. Y. et al. A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients. Can. J. Anesth. 63, 1140\u20131153 (2016).","journal-title":"Can. J. Anesth."},{"key":"29945_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-87553-3","volume-title":"Morphometry of the Human Lung","author":"ER Weibel","year":"1963","unstructured":"Weibel, E. R. Morphometry of the Human Lung (Academic Press, 1963)."},{"key":"29945_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrd2153","volume":"6","author":"JS Patton","year":"2007","unstructured":"Patton, J. S. & Byron, P. R. Inhaling medicines: Delivering drugs to the body through the lungs. Nat. Rev. Drug Discov. 6, 67\u201374 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"29945_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0169-409X(95)00113-L","volume":"19","author":"JS Patton","year":"1996","unstructured":"Patton, J. S. Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliv. Rev. 19, 3\u201336 (1996).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"29945_CR33","first-page":"355","volume":"11","author":"RA Brown Jr","year":"1983","unstructured":"Brown, R. A. Jr. & Schanker, L. S. Absorption of aerosolized drugs from the rat lung. Drug. Metab. Dispos. 11, 355\u2013360 (1983).","journal-title":"Drug. Metab. Dispos."},{"key":"29945_CR34","first-page":"79","volume":"14","author":"LS Schanker","year":"1986","unstructured":"Schanker, L. S., Mitchell, E. W. & Brown, R. A. Jr. Species comparison of drug absorption from the lung after aerosol inhalation or intratracheal injection. Drug Metab. Dispos. 14, 79\u201388 (1986).","journal-title":"Drug Metab. Dispos."},{"key":"29945_CR35","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1053\/j.jvca.2018.01.031","volume":"32","author":"P Gavra","year":"2018","unstructured":"Gavra, P., Denault, A. Y., Theoret, Y., Perrault, L. P. & Varin, F. Pharmacokinetics and pharmacodynamics of nebulized and intratracheal milrinone in a swine model of hypercapnia pulmonary hypertension. J. Cardiothorac. Vasc. Anesth. 32, 2130\u20132138 (2018).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR36","first-page":"1878","volume":"47","author":"IM Keith","year":"1987","unstructured":"Keith, I. M., Olson, E. B. Jr., Wilson, N. M. & Jefcoate, C. R. Immunological identification and effects of 3-methylcholanthrene and phenobarbital on rat pulmonary cytochrome P-450. Cancer Res. 47, 1878\u20131882 (1987).","journal-title":"Cancer Res."},{"key":"29945_CR37","first-page":"L394","volume":"269","author":"CM Ji","year":"1995","unstructured":"Ji, C. M. Pulmonary cytochrome P-450 monooxygenase system and Clara cell differentiation in rats. Am. J. Physiol. 269, L394\u2013L402 (1995).","journal-title":"Am. J. Physiol."},{"key":"29945_CR38","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/jps.10386","volume":"92","author":"A Tronde","year":"2003","unstructured":"Tronde, A. et al. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: Structure\u2013absorption relationships and physicochemical profiling of inhaled drugs. J. Pharm. Sci. 92, 1216\u20131233 (2003).","journal-title":"J. Pharm. Sci."},{"key":"29945_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/dmd.106.010652","volume":"35","author":"MJ Avram","year":"2007","unstructured":"Avram, M. J. et al. Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs. Drug Metab. Dispos. 35, 262\u2013267 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"29945_CR40","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1002\/jps.20694","volume":"95","author":"JD Rabinowitz","year":"2006","unstructured":"Rabinowitz, J. D. et al. Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation. J. Pharm. Sci. 95, 2438\u20132451 (2006).","journal-title":"J. Pharm. Sci."},{"key":"29945_CR41","first-page":"1406","volume":"47","author":"R Dhand","year":"2002","unstructured":"Dhand, R. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir. Care 47, 1406\u20131416 (2002).","journal-title":"Respir. Care"},{"key":"29945_CR42","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/jps.2600731029","volume":"73","author":"RM Stroshane","year":"1984","unstructured":"Stroshane, R. M., Koss, R. F., Biddlecome, C. E., Luczkowec, C. & Edelson, J. Oral and intravenous pharmacokinetics of milrinone in human volunteers. J. Pharm. Sci. 73, 1438\u20131441 (1984).","journal-title":"J. Pharm. Sci."},{"key":"29945_CR43","first-page":"145","volume":"73","author":"J Edelson","year":"1986","unstructured":"Edelson, J. et al. Pharmacokinetics of the bipyridines amrinone and milrinone. Circulation 73, 145\u2013152 (1986).","journal-title":"Circulation"},{"key":"29945_CR44","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/bja\/72.4.426","volume":"72","author":"PA Das","year":"1994","unstructured":"Das, P. A. et al. Disposition of milrinone in patients after cardiac surgery. Br. J. Anaesth. 72, 426\u2013429 (1994).","journal-title":"Br. J. Anaesth."},{"key":"29945_CR45","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1053-0770(05)80319-2","volume":"9","author":"SG De Hert","year":"1995","unstructured":"De Hert, S. G. et al. Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 9, 264\u2013271 (1995).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"29945_CR46","first-page":"783","volume":"81","author":"JF Butterworth 4th","year":"1995","unstructured":"Butterworth, J. F. 4th., Hines, R. L., Royster, R. L. & James, R. L. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth. Analg. 81, 783\u2013792 (1995).","journal-title":"Anesth. Analg."},{"key":"29945_CR47","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/00000542-199409000-00014","volume":"81","author":"JM Bailey","year":"1994","unstructured":"Bailey, J. M., Levy, J. H., Kikura, M., Szlam, F. & Hug, C. C. Jr. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology 81, 616\u2013622 (1994).","journal-title":"Anesthesiology"},{"key":"29945_CR48","volume-title":"Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists","author":"Y Kwon","year":"2001","unstructured":"Kwon, Y. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists (Springer, 2001)."},{"key":"29945_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/js970168r","volume":"87","author":"W Krzyzanski","year":"1998","unstructured":"Krzyzanski, W. & Jusko, W. J. Integrated functions for four basic models of indirect pharmacodynamic response. J. Pharm. Sci. 87, 67\u201372 (1998).","journal-title":"J. Pharm. Sci."},{"key":"29945_CR50","doi-asserted-by":"publisher","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau, G. et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 62, D34\u2013D41 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"29945_CR51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1213\/ANE.0000000000006192","volume":"136","author":"M Elmi-Sarabi","year":"2023","unstructured":"Elmi-Sarabi, M. et al. Pulmonary vasodilator response of combined inhaled epoprostenol and inhaled milrinone in cardiac surgical patients. Anesth. Analg. 136, 282\u2013294 (2023).","journal-title":"Anesth. Analg."},{"key":"29945_CR52","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12630-020-01832-z","volume":"68","author":"MA Azzam","year":"2021","unstructured":"Azzam, M. A. et al. A proposed algorithm for combining transcranial Doppler ultrasound monitoring with cerebral and somatic oximetry: A case report. Can. J. Anesth. 68, 130\u2013136 (2021).","journal-title":"Can. J. Anesth."},{"key":"29945_CR53","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/j.jtcvs.2019.05.064","volume":"159","author":"A Denault","year":"2020","unstructured":"Denault, A. et al. Postoperative right ventricular dysfunction-Integrating right heart profiles beyond long-axis function. J. Thorac. Cardiovasc. Surg. 159, e315\u2013e317 (2020).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"29945_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2022.12.007","author":"M Elmi-Sarabi","year":"2022","unstructured":"Elmi-Sarabi, M. et al. Inhaled epoprostenol and milrinone effect on right ventricular pressure waveform monitoring. Can. J. Cardiol. https:\/\/doi.org\/10.1016\/j.cjca.2022.12.007 (2022).","journal-title":"Can. J. Cardiol."},{"key":"29945_CR55","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1213\/ANE.0000000000004793","volume":"131","author":"X Hu","year":"2020","unstructured":"Hu, X. et al. Routine intraoperative inhaled milrinone and iloprost reduces inotrope use in patients undergoing cardiac surgery: A retrospective cohort pilot study. Anesth. Analg. 131, 527\u2013536 (2020).","journal-title":"Anesth. Analg."},{"key":"29945_CR56","first-page":"3369","volume":"20","author":"TY Kim","year":"2014","unstructured":"Kim, T. Y., Lee, S. & Jeong, C. Intraoperative efficacy of brief inhalation of milrinone on elevated pulmonary arterial pressure in patients undergoing mitral valve surgery due to mitral regurgitation. Exp. Clin. Cardiol. 20, 3369\u20133378 (2014).","journal-title":"Exp. Clin. Cardiol."},{"key":"29945_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5152\/TJAR.2019.91145","volume":"48","author":"IIA Elbaser","year":"2020","unstructured":"Elbaser, I. I. A. & El Aleem El Derie, A. A. Does inhaled milrinone facilitate weaning from cardiopulmonary bypass in children with congenital heart diseases complicated with pulmonary arterial hypertension?. Turk. J. Anaesthesiol. Reanim. 48, 127\u2013133 (2020).","journal-title":"Turk. J. Anaesthesiol. Reanim."},{"key":"29945_CR58","doi-asserted-by":"publisher","DOI":"10.5812\/aapm-122994","volume":"12","author":"S Jorairahmadi","year":"2022","unstructured":"Jorairahmadi, S., Javaherforooshzadeh, F., Babazadeh, M., Gholizadeh, B. & Bakhtiari, N. Comparison of nebulized versus intravenous milrinone on reducing pulmonary arterial pressure in patients with pulmonary hypertension candidate for open-cardiac surgery: A double-blind randomized clinical trial. Anesthesiol. Pain Med. 12, e122994 (2022).","journal-title":"Anesthesiol. Pain Med."},{"key":"29945_CR59","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/clc.4960200804","volume":"20","author":"D Moraes","year":"1997","unstructured":"Moraes, D. & Loscalzo, J. Pulmonary hypertension: Newer concepts in diagnosis and management. Clin. Cardiol. 20, 676\u2013682 (1997).","journal-title":"Clin. Cardiol."},{"key":"29945_CR60","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","volume":"41","author":"SA Nashef","year":"2012","unstructured":"Nashef, S. A. EuroSCORE II. Eur. J. Cardiothorac. Surg. 41, 734\u2013744 (2012).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"29945_CR61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/FTD.0000000000000072","volume":"36","author":"P Gavra","year":"2014","unstructured":"Gavra, P. et al. A specific and sensitive HPLC-MS\/MS micromethod for milrinone plasma levels determination after inhalation in cardiac patients. Ther. Drug Monit. 36, 663\u2013668 (2014).","journal-title":"Ther. Drug Monit."},{"key":"29945_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/BF00635891","volume":"29","author":"R Larsson","year":"1986","unstructured":"Larsson, R., Liedholm, H., Andersson, K. E., Keane, M. A. & Henry, G. Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment. Eur. J. Clin. Pharmacol. 29, 549\u2013553 (1986).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"29945_CR63","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/bmc.3123","volume":"28","author":"P Gavra","year":"2014","unstructured":"Gavra, P., Nguyen, A. Q., Beauregard, N., Denault, A. Y. & Varin, F. High-performance liquid chromatography assay using ultraviolet detection for urinary quantification of milrinone concentrations in cardiac surgery patients undergoing cardiopulmonary bypass. Biomed. Chromatogr. 28, 1084\u20131089 (2014).","journal-title":"Biomed. Chromatogr."},{"key":"29945_CR64","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41598-020-58902-x","volume":"10","author":"AQ Nguyen","year":"2020","unstructured":"Nguyen, A. Q., Denault, A. Y., Theoret, Y., Perrault, L. P. & Varin, F. Inhaled milrinone in cardiac surgical patients: A pilot randomized controlled trial of jet vs mesh nebulization. Sci. Rep. 10, 2069 (2020).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29945-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T02:03:00Z","timestamp":1677808980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29945-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29945"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29945-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"8 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Andr\u00e9 Y. Denault is a consultant (2020) for CAE Healthcare; speaker (2017) and consultant (2020) for Masimo; and speaker (2019) for Edwards Lifesciences. He received a research grant (equipment) (2019) from Edwards Lifesciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3557"}}